Introduction
Anthony Bova is an associate in Nixon Peabody’s Corporate Transactions practice group. Anthony focuses his practice on a wide range of corporate matters, including public and private mergers and acquisitions, corporate formation and start-up structuring, private equity considerations, contract drafting and analysis, strategic guidance and business counseling, and many other commercial transactions.
My focus
General Corporate
I counsel public and private companies of all sizes, both here in the United States and abroad, in a variety of industries, including healthcare, emerging technologies, food and beverage (with a particular focus on alcoholic beverages), manufacturing, distribution, and numerous professional services. I advise my clients on all aspects of their business, from early-stage needs, such as formation and governance considerations, equity incentive planning, financing, regulatory compliance, and contract drafting and analysis, to mid- and later-stage needs such as capital raising (debt and equity), spin-offs, divestitures, and exit events.
I take special pride in representing family-run businesses, as I myself grew up in a four-generation family-run business in Boston’s North End.
Mergers and Acquisitions
I regularly represent strategic and private-equity buyers and sellers in a wide array of corporate mergers and acquisitions. My particular focus is on the middle market, navigating deals with a total enterprise value between a few million dollars and hundreds of millions of dollars. Regardless of transaction size, my focus is on achieving my client’s goals, optimizing the manner in which we achieve them, and finding practical ways to jump over inevitable hurdles.
Food and Beverage
For years I have represented local, national, and international alcoholic beverage companies in all three tiers—production, distribution, and retail—in a variety of matters involving licensing, wholesaler franchise-protection, compliance and risk-management, contractual preparation, and executive employment.
Representative experience
- Represented Health Catalyst (NASDAQ:HCAT) in numerous strategic acquisitions, totaling over $325M.
- Represented a family-owned and operated fastener distribution company in an equity sale to a private equity buyer for $130M.
- Represented SAES Getters S.p.A. (SG on the BIT exchange) in the carve-out and sale of its medical Nitinol business for $900M to a private equity backed strategic buyer.
- Represented National Railway Equipment Co. in the sale of substantially all of its assets to a private equity buyer.
- Represented a private equity-backed strategic buyer in a $70M acquisition of a cloud-based healthcare business.
- Represented a private equity buyer in a platform acquisition of a home healthcare and franchise business for $34M.
- Represented a private equity buyer in multiple add-on acquisitions of disaster remediation businesses totaling over $20M.
- Represented Obagi Cosmeceuticals, Inc.’s stockholders on its three-way, $1.2B de-SPAC merger with Waldencast Acquisition Corp. and Milk Makeup.
- Represented a private equity buyer in the acquisition of a specialty packaging provider for the candy industry totaling over $100M.
- Represented a Japanese company in an equity sale of a subsidiary that operated the Port of Jacksonville, FL to a private equity-backed strategic buyer for $31.5M.
- Represented a freight brokerage provider in an equity sale to a strategic acquirer for approximately $40M.
- Represented an Australian financial services firm in the sale of its infrastructure mezzanine debt platform to a private equity buyer for approximately $400M.
- Represented a private equity buyer in the acquisition of multiple California-based ski resorts totaling over $50M.
- Represented many buyers and sellers in the food and beverage space, including restaurants, pubs and bakeries.
Looking ahead
We continue to see misaligned pricing expectations between buyers and sellers. Interest rate reductions should ease this disparity for two primary reasons. First, buyers with access to more affordable capital can justify incrementally higher purchase prices. Second, more affordable capital allows more potential buyers to enter the market, which should increase competition and raise purchase prices. We expect the result to be increased transaction volume over the next 12-18 months.
/Insights
- “The Impacts of New Tariffs on M&A Activity,” February 14, 2025
- "Hot Topics in Artificial Intelligence for Middle Market Dealmaking," June 17, 2024
-
"Hot Topics: Private Equity Market Outlook 2024,"March 4, 2024
- “Hot Topics in National Defense Spending and Cybersecurity,” November 14, 2023
- “Macro Trends in the Consumer Products M&A Market,” April 16, 2023
- “Healthcare M&A Trends and Opportunities for 2023,” February 13, 2023
- “2023 Private Equity and M&A Outlook,” November 20, 2022
- Speaker, “Massachusetts Alcoholic Beverage Sales & Distribution Law,” MCLE New England, February 2021
In the news
- Manufacturing Dive
10 manufacturing acquisitions to know from Q1
April 16, 2025This article covers notable M&A insights and deal activity from the first quarter of this year. The article references and links to a recent NP article written by Boston Corporate associate Anthony Bova, discussing the impacts of new tariffs on M&A activity.
- Modern Restaurant Management |
Restaurant deal landscape for mid-year 2024
July 16, 2024Boston Corporate associates Anthony Bova and Rob Pethick are featured in this Q&A, discussing the current deal landscape in the restaurant industry. Rob and Anthony provide insight on what is fueling deal activity right now, how the growth of the private credit market could be beneficial in this space, and other trends that will impact the industry moving forward.
- The Deal
Resonetics to acquire two SAES units
Dec 9, 2022The following article covers Resonetics LLC’s $900 million agreement to acquire Memry Corp. and SAES Smart Materials Inc. from NP client SAES Getters SpA. The article mentions Manchester partner and Private Equity & Family Offices team leader Phil Taub and Boston partner Amy O’Keefe, both of the Corporate group, for leading the NP team representing SAES Getters on U.S. legal matters. The team also includes Chicago partner and Global Finance co-leader Rob Drobnak; Corporate partners Alexandra Lopez-Casero and Thomas McCord from Boston, Andrew Share from Manchester, and Sean Clancy from Washington, DC; Affordable Housing & Real Estate partners Mark Beaudoin from Manchester and Alison Torbitt from San Francisco; Boston Labor & Employment partner Jeff Gilbreth; Rochester Intellectual Property partner Kristen Walsh; Washington, DC Complex Disputes partner and Antitrust leader Gordon Lang; Manchester Government Investigations & White-Collar Defense partner Mark Knights; Rochester counsel and Cybersecurity & Privacy deputy leader Jenny Holmes; Boston Corporate counsel David Crosby; Washington, DC Complex Disputes counsel Brian Whittaker; Albany Affordable Housing & Finance counsel Dana Stanton; Corporate associates Shaziah Singh from New York, Anthony Bova from Boston, Corey Habib from Manchester, and Hrishikesh Shah from Chicago; and Manchester Corporate department attorney Dave Zimmermann.
- The American Lawyer
Deal Watch: Private equity hits new heights
Nov 22, 2021This article on the surge in private equity deals includes NP for advising the owners of skin care brand Obagi in its $1.2 billion business combination agreement with Waldencast Acquisition Corp. and the spinoff of Obagi’s operations in China.
The NP team was led by David Cheng, chair and managing partner of the firm's China and Asia-Pacific practice, and New York City Corporate partners Michael Smith and Richard Langan. The team that advised Obagi also included Chicago Corporate partner David Brown, Rochester Corporate partner Jeremy Wolk, Washington, DC Complex Commercial Disputes partner and Antitrust team leader Gordon Lang, and Washington, DC Corporate senior counsel Kenneth Silverberg. Other members of the team included Boston Corporate associate Anthony Bova and Chinese legal consultant Kelly Xiang.
- Bloomberg Law
Four firms lead three-way SPAC to create new beauty platform
Nov 18, 2021This article covering a roughly $1.2 billion merger of skin care and beauty brands with a special purpose acquisition company mentions NP for advising the owners of skin care brand Obagi in its business combination agreement with Waldencast Acquisition Corp. and the spinoff of Obagi's operations in China.
The NP team was led by David Cheng, chair and managing partner of the firm's China and Asia-Pacific practice, and New York City Corporate partners Michael Smith and Richard Langan. The team that advised Obagi also included Chicago Corporate partner David Brown, Rochester Corporate partner Jeremy Wolk, Washington, DC Complex Commercial Disputes partner and Antitrust team leader Gordon Lang, and Washington, DC Corporate senior counsel Kenneth Silverberg. Other members of the team included Boston Corporate associate Anthony Bova and Chinese legal consultant Kelly Xiang.
- Modern Restaurant Management
MRM research roundup: Mid-August 2021 edition
This state-of-the-restaurant-industry and outlook article includes NP’s Q3 Food & Beverage Crystal Ball, covering trends around labor shortages, ransomware attacks, wildfires, and brewery distribution agreements. The insights were provided by Intellectual Property co-leader and Cybersecurity & Privacy team leader Jason Kravitz and Corporate associate Anthony Bova, both in Boston; Providence Labor & Employment counsel Jessica Schachter Jewell; and San Francisco counsel Ian T. O’Banion, and Albany associate Dana P. Stanton, both of the Affordable Housing & Real Estate groupAug 16, 2021
Admitted to practice
Massachusetts
U.S. District Court, District of Massachusetts
U.S. Court of Appeals, First Circuit
Education
Suffolk University Law School, J.D. Summa Cum Laude, Production Editor, Suffolk University Law Review
Boston College, B.A.
Professional activities
- Advisory Board Member, Boston Public Market, a nonprofit, year-round marketplace featuring New England artisans and food producers
Recognition
- Selected, through a peer-review survey, for inclusion in Best Lawyers: Ones to Watch 2024 in the fields of Commercial Litigation and Corporate Law in Boston, MA; listed in Best Lawyers: Ones to Watch since 2021
- Super Lawyers “Rising Star,” 2015–2023
Insights And Happenings
View AllProfessionals in the Practice Area
View AllChristopher P. Keefe
Partner / Chair, Business & Finance Department- Boston
- Office:+1 617.345.1350
- ckeefe@nixonpeabody.com
-
Todd Tidgewell
Partner / Leader, Corporate Practice Group- Albany
- Office:+1 518.427.2705
- ttidgewell@nixonpeabody.com
-
Lori B. Green
Partner / Co-Leader, M&A & Corporate Transactions Team / Co-Leader, Cannabis Practice- Rochester
- Office:+1 585.263.1236Mobile:+1 585.281.3076
- lgreen@nixonpeabody.com
-
Robert A. Drobnak
Partner / Practice Group Co-leader, Global Finance- Chicago
- Office:+1 312.977.4348
- radrobnak@nixonpeabody.com
-
